Betrixaban
- Catalog NO.:A857639
- CAS No. : 330942-05-7
- Molecular Formula:C23H22ClN5O3
- Molecular Weight: 451.91
Note*
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Bulk Inquiry
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Quality Control&SDS
Product Details
CAS Number | 330942-05-7 | Appearance | |
Catalog Number | A857639 | MDL Number | MFCD16038040 |
Molecular Formula | C23H22ClN5O3 | Molecular Weight | 451.91 |
Boiling Point | Melting Point | ||
Flash Point | Density | ||
Synonyms | PRT021; MLN-1021;N-(5-Chloropyridin-2-yl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxybenzamide | ||
Storage Condition | Store in a tightly closed container,in a cool and dry place |
Safety
GHS Pictogram | |||
Signal Word | Danger | UN Number | 2811 |
Hazard Statements | H302-H373 | Class | 6.1 |
Precautionary Statements | P260-P270-P301+P312-P330 | Packing Group | Ⅲ |
Description
Betrixaban, also known as PRT054021, MK-4448; PRT-021; PRT-054021; MLN-1021, is a potent, orally active and highly selective factor Xa inhibitor undergone human clinical trials for prevention of embolism after knee surgery, and prevention of stroke following atrial fibrillation. Betrixaban is currently being studied in a human clinical trial for extended duration thromboprophylaxis to prevent venous thromboembolism in acute medically ill patients. |